Surrogate reads like anecdotal is back in play.
Post# of 147880
(Total Views: 393)
Posted On: 11/05/2024 12:06:38 AM
Surrogate reads like anecdotal is back in play.
" The FDA can grant accelerated approval based on a surrogate endpoint, which is something that is thought to predict clinical benefit. This allows for earlier access to drugs while confirmatory studies are still
___
If protocol includes Interim, with Dr. J, Syneos & Max, I would expect a fair Safety Board recommendation.
Of course we'd still need FDA to accept a SB recommendation of anything related to an Accelerated Approval.
Dr. J's FDA relationship comments sure ringing bells now.
" The FDA can grant accelerated approval based on a surrogate endpoint, which is something that is thought to predict clinical benefit. This allows for earlier access to drugs while confirmatory studies are still
___
If protocol includes Interim, with Dr. J, Syneos & Max, I would expect a fair Safety Board recommendation.
Of course we'd still need FDA to accept a SB recommendation of anything related to an Accelerated Approval.
Dr. J's FDA relationship comments sure ringing bells now.
(1)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼